Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

Renal impairment is frequent in patients with multiple myeloma and is correlated with an inferior prognosis. This analysis evaluates the prognostic role of renal impairment in patients with myeloma treated with bortezomib before and after autologous stem cell transplantation within a prospective ran...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Scheid, Christof, Sonneveld, Pieter, Schmidt-Wolf, Ingo G.H., van der Holt, Bronno, el Jarari, Laila, Bertsch, Uta, Salwender, Hans, Zweegman, Sonja, Blau, Igor Wolfgang, Vellenga, Edo, Weisel, Katja, Pfreundschuh, Michael, Jie, Kon-Siong, Neben, Kai, van de Velde, Helgi, Duehrsen, Ulrich, Schaafsma, M. Ron, Lindemann, Walter, Kersten, Marie José, Peter, Norma, Hänel, Mathias, Croockewit, Sandra, Martin, Hans, Wittebol, Shulamiet, Bos, Gerard MJ, van Marwijk-Kooy, Marinus, Wijermans, Pierre, Goldschmidt, Hartmut, Lokhorst, Henk M.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2014
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007933/
https://ncbi.nlm.nih.gov/pubmed/23996482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.087585
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados